Chevron Corporation (CVX) vs Johnson & Johnson (JNJ)

Chevron Corporation is an integrated energy company engaged in worldwide oil and gas exploration, production, and refining. It is the second-largest oil company in the United States, reporting 2025 net oil-equivalent production of 3.7 million barrels per day, including 8.5 billion cubic feet of natural gas per day and 2.3 million barrels of liquids per day. The company produces energy across North America, South America, Europe, Africa, Asia, and Australia. Chevron’s refining network is concentrated in the United States and Asia, with total global refining capacity of 1.8 million barrels per day at year-end 2025. At the end of 2025, net proved reserves totaled 10.6 billion barrels of oil equivalent, including 5.7 billion barrels of liquids and 29.2 trillion cubic feet of natural gas.

Johnson & Johnson is the world’s largest and most diversified healthcare company. Its operations are organized into two segments: Innovative Medicine and MedTech, which together account for all revenue following the 2023 separation of its consumer health business, Kenvue. After restructurings completed in 2023 and 2024, the pharmaceutical segment is focused on three core therapeutic areas: immunology, oncology, and neurology. From a geographic perspective, slightly more than half of the company’s total revenue comes from the United States.